Xabier García de Albéniz, MD, ScM, PhD, is Director of Epidemiology at RTI Health Solutions. He has a background in oncology, epidemiology, and biostatistics. Dr. Garcia de Albéniz obtained his MD at the University of Navarra (Spain). He trained as a clinical oncologist in Barcelona, while he pursued a Master's degree in biostatistics. He obtained a PhD in Medicine from the University of Barcelona and a Master of Science with a concentration in Epidemiology from the Harvard School of Public Health. Dr. García de Albéniz has worked for several years within the Program on Causal Inference, Department of Epidemiology at the Harvard T.H. Chan School of Public Health, where he maintains an affiliation as a visiting scientist and as collaborator of the CAUSALab. He currently collaborates on several academic research projects in the field of cancer comparative effectiveness and development of methods for cancer research and COVID-19 prophylaxis. Dr. García de Albéniz provides oncology and methodologic expertise to RTI-HS's Epidemiology group.
Selected publications from PubMed
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal Time.
Garcia-Albeniz X, Vila-Guilera J, Zamparini M, Oliveres H, Alonso-Orduna V, Feliu J, Fernández-Montes A, Martín-Richard M, Gálvez-Munoz E, Ruiz-Casado A, Yubero-Esteban A, Aparicio J, Alcaide-Garcia J, Plazas JG, Fernandez-Martos C, Gallego-Sanchez R, Morales MG, Leno R, Esposito F, Lopez-Prades S, Cuatrecasas M, Dickerman BA, Maurel J
Cancer Med. 2026 Jun;15(6):e71950 doi: 10.1002/cam4.71950.
The TARGET guideline for reporting observational studies of interventions.
Hansford HJ, McAuley JH, Swanson SA, Islam N, Dahabreh IJ, Dickerman BA, Egger M, Garcia-Albeniz X, Golub RM, Lodi S, Moreno-Betancur M, Pearson SA, Schneeweiss S, Sterne JAC, Sharp MK, Jones MD, Stuart EA, Lee H, Hernán MA, Cashin AG
Nat Med. 2026 Jun;32(6):1954-1955 doi: 10.1038/s41591-026-04358-x.
Target Trial Emulation for Regulatory and Clinical Decision Making in Cancer.
Dickerman BA, García-Albéniz X, Hernán MA
J Clin Oncol. 2026 Apr 20;44(12):1139-1144 doi: 10.1200/JCO-25-01906.
Effectiveness of Indapamide Prolonged-Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial Emulation.
Darricarrere C, Simon V, Pladevall-Vila M, Jacquot E, Ballon M, Mangin M, Procureur D, Aguado J, Garcia-Albeniz X
Pharmacoepidemiol Drug Saf. 2026 Feb;35(2):e70295 doi: 10.1002/pds.70295.
Target Trial Emulation for the Estimation of Drug Effects in Pregnancy and Perinatal Outcomes.
Garcia-Albeniz X, Margulis A
Paediatr Perinat Epidemiol. 2026 Feb;40(2):261-263 doi: 10.1111/ppe.70116.
Help your network discover Dr. Xabier García Albeniz's clinical expertise.
